Canopy Growth (TSX:CGC): Mexico Could Legalize Marijuana in 2020!

Investor sentiment about Canopy Growth (TSX:WEED)(NYSE:CGC) stock is about as bleak as it’s ever been. This could be the perfect time to buy before Mexico legalizes marijuana.

| More on:
edit Jars of marijuana

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Mexico is about to become the world’s largest market for legal marijuana. Lawmakers must decide whether to pass a Supreme Court order striking down the marijuana ban by December 15. This news would have been huge for stocks like Canopy Growth (TSX:WEED)(NYSE:CGC) a few years ago. This year, no one seems to have noticed. 

That creates an opportunity for savvy investors to bet on an epic rebound in the world’s largest cannabis stock before the market realizes what’s happening. Here’s a closer look. 

Mexico’s marijuana market

Mexico is Latin America’s second-most populous nation. Of the 129 million Mexicans who live there, an estimated 1.4 million smoke marijuana recreationally. Also, an estimated 200,000 Mexican families are growing weed illegally already. Production and distribution of marijuana is, unsurprisingly, big business that has been dominated by cartels and criminal enterprises. 

Legalizing the substance would be a paradigm shift unlike any other. The move could create hundreds of thousands of jobs and generate billions in exports. Mexico could become the third nation to make marijuana legal on a federal level if this law is passed by the end of 2020. 

According to New Frontier data, the recreational and medical marijuana sector in Mexico could be worth US$2 billion (CA$2.6 billion) right away and much more later. 

Canopy Growth’s valuation

Canada’s marijuana sector is already worth over $2.5 billion this year. Meanwhile, the market for cannabis is between $20 and $30 billion in the United States. That means North America’s total market potential is above $25 billion already. Bear in mind that this sector is also rapidly expanding and could be worth a lot more in the next decade. 

Canopy Growth, meanwhile, has lost market value. The company is now worth only $8.9 billion. That’s despite the fact that it’s the largest cannabis producer in the world and is likely to dominate this market. 

The company also has $2 billion in cash and cash equivalents on hand. That’s worth roughly 25% of its market value. Canopy already has operations in Mexico, along with a workforce in other Latin American countries. The Canopy team can deploy this cash to acquire production facilities in Mexico if legalization materializes this year. 

This creates the perfect opportunity for investors willing to make a contrarian bet on an unloved sector. Cannabis hasn’t been a popular investment for years, and investors are wary of the industry after the bubble burst, but now there is tangible traction in the market that investors shouldn’t ignore. 

Bottom line

Investor sentiment about Canopy Growth stock is about as bleak as it’s ever been. The company is now worth just a third of its market peak in 2019. However, the underlying business has been boosted by higher consumption during the lockdown. 

Now, a potential legalization of marijuana in Mexico could open even more opportunities. Mexico’s market for recreational and medical cannabis could be just as big as Canada’s, if not bigger. Investors should watch this story closely.  

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Vishesh Raisinghani has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »